Short Interest in Apollomics, Inc. (NASDAQ:APLMW) Declines By 99.0%

Apollomics, Inc. (NASDAQ:APLMW) was the target of a large drop in short interest during the month of December. As of December 31st, there was short interest totalling 700 shares, a drop of 99.0% from the December 15th total of 68,200 shares. Based on an average daily volume of 82,000 shares, the short-interest ratio is currently 0.0 days.

Apollomics Price Performance

Shares of APLMW opened at $0.01 on Monday. The firm has a fifty day moving average of $0.01 and a 200-day moving average of $0.01. Apollomics has a 1 year low of $0.01 and a 1 year high of $0.04.

About Apollomics

Apollomics, Inc, a biotechnology company, engages in the discovery and development of mono and combination oncology therapies to harness the immune system and target specific molecular pathways to inhibit cancer. Its pipeline consists of various development-stage assets, including novel and humanized monoclonal antibodies that restore the body's immune system to recognize and kill cancer cells, and targeted therapies against uncontrolled growth signaling pathways.